Skip to main content
EIC Community
 All events
image

The Pioneer Programme session on regulatory topics for medicinal products, powered by EIC Tech 2 Market x European Medicine Agency (EMA)

A joint session on regulatory topics for medicinal products organised by EIC Tech to Market x European Medicine Agency (EMA). The online session will introduce the regulatory framework for medicinal products and will focus on regulatory compliance with practical steps on how to navigate it in your business.

Like (6)
Users 2
Comments 0
Documents 0

A joint session on regulatory topics for medicinal products organised by EIC Tech to Market x European Medicine Agency (EMA). The online session will introduce the regulatory framework for medicinal products and will focus on regulatory compliance with practical steps on how to navigate it in your business.

About

As part of the EIC Tech to Market (T2M) Programme, the European Innovation Council (EIC) invites EIC Pathfinder (former FET-Open and FET- Proactive), EIC Transition, and all innovators eligible for EIC Tech to Market (see section “Who can apply”) to attend a dedicated session on the regulatory framework for medicinal products, organised in collaboration with the European Medicines Agency (EMA)

The session will take place online, on Wednesday, 31 January 2024 from 16:00 to 18:30 CET.

The online session will introduce the regulatory framework for medicinal products and will focus on regulatory compliance with practical steps on how to navigate it in your business. 

 

Make sure to apply until 26 January 2024! 

 

As part of the EIC T2M Pioneer Programme, the European Medicines Agency (EMA) is making a presentation for EIC beneficiaries and all innovators eligible for EIC Tech to Market (see section “Who can apply”).

This session will allow participating projects to interact with representatives of the EMA and obtain advice on optimizing their interfaces and regulatory strategy. Then, the session will be followed by an exchange (Q&A) with an entrepreneur, Mr. Florent Perin-Dureau, co-founder & CMO of ReST Therapeutics (EIC Accelerator beneficiary), which will enrich the operational and strategic perspectives of the participating projects, by sharing the experience of "someone who has done it before”.

 

Date: Wednesday, 31 January 2024 from 16h00 to 18h30 CET

Where: Online

Agenda:

16:00 – 17:15: Helene Casaert, Scientific officer at EMA

17:15 – 18:30: Q&A session with Mr. Florent Perin-Dureau, cofounder & CMO, REST Therapeutics

 

Who can apply?

The application to this initiative is open to EIC Pathfinder (ex. FET-Open and FET-Proactive), EIC Transition, ERC-POC, Women TechEU beneficiaries and EIC Seal of Excellence holders. 

The availability is limited (up to 70 spots) and a selection committee will choose the applicants working in the topic area. The selected applicants will receive a confirmation email with the invitation link one week before the start of the session.

 

EIC Business Acceleration Services

This opportunity is brought to you by the EIC Business Acceleration Services through its Tech 2 Market programme

To explore further opportunities, keep an eye on our events page.

The services to be delivered will cover EIC beneficiaries from all the countries participating in the EIC programme, namely, all the 27 EU Member States and Horizon Europe Associated Countries.

To learn more about EIC Tech to Market (T2M) programmes, check out the FAQ page.

 

Cancellation policy

Cancellations will only be considered in duly documented cases of “force majeure”. Unjustified cancellation can lead to exclusion in future Business Acceleration Services events.

Should you have any questions regarding the event or your eligibility, please contact us through our contact page (please choose “EIC T2M Entrepreneurship programme” as the subject).